| Literature DB >> 29601533 |
Harshvardhan Modh1, Thomas Scheper2, Johanna-Gabriela Walter3.
Abstract
Magnetic beads (MBs) are versatile tools for the purification, detection, and quantitative analysis of analytes from complex matrices. The superparamagnetic property of magnetic beads qualifies them for various analytical applications. To provide specificity, MBs can be decorated with ligands like aptamers, antibodies and peptides. In this context, aptamers are emerging as particular promising ligands due to a number of advantages. Most importantly, the chemical synthesis of aptamers enables straightforward and controlled chemical modification with linker molecules and dyes. Moreover, aptamers facilitate novel sensing strategies based on their oligonucleotide nature that cannot be realized with conventional peptide-based ligands. Due to these benefits, the combination of aptamers and MBs was already used in various analytical applications which are summarized in this article.Entities:
Keywords: analytical applications; aptamer; electrochemical assays; magnetic beads; optical assays; point-of-care-testing
Mesh:
Substances:
Year: 2018 PMID: 29601533 PMCID: PMC5948603 DOI: 10.3390/s18041041
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Figure 1(A) Target-induced structure switching (TISS) type of assay. Here, the interaction between an aptamer and a target molecule leads to change in the conformation of the aptamer. The conformational changes can be exploited for signal generation, e.g., by using an electroactive molecule (EA) fused to the aptamer. In the figure, MGCE is a magnetic glass carbon electrode; (B) Target-induced dissociation (TID) type of assay. Here, the aptamer is hybridized with a complementary oligonucleotide (cDNA). The interaction between a target molecule and an aptamer leads to release of the cDNA sequence from the aptamer. The release of the cDNA can provide different types of signals in different assay formats, in the given example FRET-is used for signal generation. Adapted from [3] with permission. Copyright 2014, De Gruyter.
Figure 2Composition of magnetic beads (MBs) used in analytical applications.
Examples of coupling magnetic beads in aptamer-based analytical applications.
| Method | Analytes | Detection Limit | Reference |
|---|---|---|---|
| Differential pulse voltammetry (DPV) | Human activated protein C | 2.35 µg mL−1 | [ |
| DPV | Thrombin | 5.5 fM | [ |
| DPV | Thrombin | 5 nM | [ |
| DPV | Human liver hepatocellular carcinoma cells (HepG2) | 15 cells mL−1 | [ |
| DPV | Platelet derived growth factor BB (PDGF BB) | 0.22 fM | [ |
| DPV | Adenosine | 0.05 nM | [ |
| DPV | Hg2+ | 0.33 nM | [ |
| Squarewave voltammetry (SWV) | Tumor necrosis factor-alpha (TNF-α) | 10 pg mL−1 | [ |
| SWV | Ochratoxin A | 0.07 pg mL−1 | [ |
| Potentiometric carbon-nanotube aptasensor | Variable surface glycoprotein from African Trypanosomes | 10 pM | [ |
| Direct Potential Measurement | 10 cfu mL−1 | [ | |
| Chronopotentiometry | 10 cfu mL−1 | [ | |
| Electrochemical impedance spectroscopy | 25 cfu mL−1 | [ | |
| Impedimetric microfluidic analysis | Protein Cry1Ab | 0.015 nM | [ |
| Microfluidic impedance device | Thrombin | 0.01 nM | [ |
| Electrochemiluminescence resonance energy transfer system | β-amyloid | 4.2 × 10−6 ng mL−1 | [ |
| Ratiometric electrochemiluminescence | Cancer cells | 150 cells mL−1 | [ |
| Signal-on fluorescent aptasensor | Ochratoxin A | 20 pg mL−1 | [ |
| Aptamer-conjugated upconversion nanoprobes assisted by magnetic separation | Circulating tumour cells | 20 cells mL−1 | [ |
| Enzyme-linked aptamer assay | Oxytetracycline | 0.88 ng mL−1 | [ |
| Colorimetric assay (Methylene Blue-based) | Hg(II) | 0.7 nM | [ |
| Chemiluminescent | Hepatitis B Virus | 0.1 ng mL−1 | [ |
| Chemiluminescence (integrated microfluidic system) | Glycated haemoglobin | 0.65 g dL−1 for HbA1c and 8.8 g dL−1 for Hb | [ |
| Molecular embedded SERS aptasensor | Aflatoxin B1 | 0.0036 ng mL−1 | [ |
| Universal SERS aptasensor | Aflatoxin B1 | 0.54 pg mL−1 | [ |
| Induced Target-Bridged Strategy | platelet derived growth factor BB | 3.2 pg mL−1 | [ |
| Quartz crystal microbalance sensor | 100 cfu mL−1 | [ | |
| Magnet-quartz crystal microbalance system | Acute leukemia cells | 8 × 103 cells mL−1 | [ |
| Apta-qPCR | ATP | 17 nM | [ |
| Apta-qPCR | Ochratoxin A | 0.009 ng mL−1 | [ |
| Rolling circle amplification | Cocaine | 0.48 nM | [ |
| Micromagnetic aptamer PCR | PDGF-BB | 62 fM | [ |
| Real-time PCR | 100 cfu mL−1 | [ | |
| Magnetic nanosensors | CCRF-CEM cell | 40 cells mL−1 | [ |
| Magnetic relaxation switch | 50 cfu mL−1 | [ | |
Figure 3Utilization of MBs in aptamer-based electrochemical assays. (A) Using an electric signal mediator. Here, the electroactive molecules (HRP) were brought close to the electrode using aptamer-modified MBs. Reproduced with permission from [56]. Copyright 2012, Royal Society of Chemistry; (B) Signal-on type of electrochemical assay. The interactions between aptamers and the target molecules (Chloramphenicol and PCB 72) lead to generation of electrochemical signal. Reproduced with permission [90]. Copyright 2015, Elsevier; (C) Signal off type of electrochemical assay. In this type of assay, the interaction between the aptamer and the target molecule leads to reduction in electric signal. Reproduced with permission from [62]. Copyright 2017, Springer.
Figure 4Fluorescence-based assays. (A) Combining fluorophores and quencher molecules. Here the interaction between the aptamer and the target molecule leads to the release of quencher molecule and the increase of fluorescence signal. Reproduced with permission from [97]. Copyright 2017, Elsevier; (B) Label-free assay. Being oligonucleotides, aptamers can specifically interact with dyes specific for ssDNA or dsDNA. In this example, Tb3+ was used which interacts specifically with ssDNA (cDNA), which was released due to TID from ochratoxin A (OTA) aptamer. Reproduced with permission from [72]. Copyright 2013, Elsevier.
Figure 5Chemiluminescence assay. This assay is based on TID. Here, the interaction between the aptamer and the target molecule (cocaine) caused the release of cDNA attached to HRP-modified AuNPs. Released HRP generated chemiluminescence signal which was proportional to cocaine concentration. Reproduced with permission from [114]. Copyright 2011, Springer.
Figure 6Surface-enhanced Raman scattering-based assays. (A) Immobilization of aflatoxin B1 (AFB1) aptamer on gold nanorods (AuNRs). (B) Immobilization of cDNA on chitosan-modified MBs. (C) Schematic representation of AFB1 measurement. Here, the binding of AFB1 induced the release of cDNA and, in turn, AuNRs from the MBs and a decrease in SERS signal was observed. Reproduced with permission from [78]. Copyright 2018, Elsevier.
Figure 7Apta-qPCR. This assay is based on TID, where the interaction of the target molecules (ochratoxin A) caused the release of aptamer from the cDNA-modified MBs. The released aptamers were quantified using qPCR. Reproduced with permission from [53]. Copyright 2017, Wiley.